At Axis-Shield, innovation is fundamental to our business. There is an increasing need for new diagnostic tests in many disease areas.
We are continually striving to develop improved methods to diagnose disease, employing both in-house expertise and our links with external centres of excellence.
Identifying these diseases quickly and efficiently can be vital in maintaining a patient's quality of life.
New drug treatments are evolving alongside innovative diagnostics, which is leading to improved patient management and monitoring of treatment efficacy.
At Axis-Shield, innovation is fundamental to our business. There is an increasing need for new diagnostic tests in many disease areas.
We are continually striving to develop improved methods to diagnose disease, employing both in-house expertise and our links with external centres of excellence.
Identifying these diseases quickly and efficiently can be vital in maintaining a patient's quality of life.
New drug treatments are evolving alongside innovative diagnostics, which is leading to improved patient management and monitoring of treatment efficacy.

Main

HBA1C

Our new HbA1c immunoassay combines high
performance with a number of convenient
features

ANTI-CCP

Our Anti-CCP portfolio now includes the first
CE-marked clinical chemistry assay
.

HOMOCYSTEINE

Axis Shield’s most widely distributed product
is our clinical chemistry Enzymatic
Homocysteine assay

OEM

Full-service development, manufacturing and
supply of OEM products is one of our core
strengths